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Abstract 
Background: To  assess  disease burden of  nausea 
and vomiting of pregnancy ( NVP) and to perform  
external validity of the 24 hour PUQE score by 
examining its ability to evaluate various 
characteristics associated with NVP. 
Methods: In this  cross sectional study pregnant 
ladies with nausea and vomiting were included. 
PUQE -24 score and well-being scores  were 
recorded. Chi square and fisher-exact test were used 
to assess association between PUQE score severity  
and qualitative variables. One-way ANOVA was 
used to find association between  PUQE-24  score 
and wellbeing score.  P value of  <0.05  was taken as 
significant. 
Results: A total of 117 patients at mean gestational  
age 10.61 weeks(±2.12) presented with  NVP. Mild 
PUQE score was seen in 54.7%, moderate in 39.9% 
and severe in 15.4%. PUQE -24 score had significant 
association with severity of NVP, need of 
hospitalization,ER visits,need of intravenous 
antiemetics and fluids and lower well-being 
score.(p<0.05)   
Conclusion:For the assessment of NVP symptoms, 
the PUQE- 24 seems as a reliable tool. It is simple 
and can help in patient management and follow up. 
Key Words:24 hour –Pregnancy Unique  
Quantification, Emesis Scale, Nausea and vomiting 
of pregnancy (NVP)  
 
Introduction 
Most pregnant women suffer from nausea and 
vomiting of pregnancy (NVP). Around 70-80% of the 
pregnant women suffer from nausea while about 50% 
suffer from  vomiting.1 The symptoms of NVP vary in 
severity  from mild to  severe, with hyperemesis 
gravidarum (HG) at the extreme end of spectrum. HG 
is described by excessive  nausea and vomiting, 
resulting in dehydration, nutritional deprivation and 
electrolyte disturbances and  loss of 5% of pre-
pregnancy weight  which often making hospitalization 
necessary.1,2Health care providers often tend to 
underestimate impact of NVP due to its high 
prevalence and often self-limiting course . NVP does 
not lead to adverse pregnancy outcome in most of the 
cases,it badly impacts women’s lives in many ways. 1,3 
In 2002 the Pregnancy-Unique  Quantification  
of Emesis (PUQE) scoring system was introduced. It 
assessed the severity of  nausea  and vomiting  
in pregnancy (NVP) centered on three physical 
symptoms: nausea, vomiting, and retching over the 
preceeding 12 hours.1,4Later 24-hour PUQUE score 
was introduced-  an extension of the original PUQE, 
by assessing NVP over previous  24 hours. This 
extension to 24 hours is considered more clinically 
pertinent.4,5 The assessment of symptoms over 12 
hours only  may incorporate sleeping hours and so  
may not satisfactorily assess the severity and length of 
the symptoms.4 
 So far no studies have been done in Pakistani women 
to validate the 24 hour PUQE score. Cultural 
differences and differences between countries with 
respect to health care systems could alter results as 
data obtained in other countries 1 may not apply for 
the our local pregnant population where most 
antenatal care is rendered by private sector and 
patients have to pay out of pocket.1,6 
 
Patients and  Methods  
This was a cross sectional study conducted from 1st 
May to July 2018 at MCH center,Unit 1 Pakistan 
Institute of Medical Sciences after approval of hospital 
ethical review board. All patients who consented to be 
included in the study and presented to OPD and 
emergency room(ER) with NVP with singleton, viable 
pregnancy upto 16 weeks gestation were included. 
Patients with urinary tract infections, gestational 
trophoblastic disease, hypertension, diabetes, 
threatened miscarriage, ectopic gestation, thyroid, 
cardiac and liver disease and diarrheal illness were 
excluded . Intake of oral or intravenous antiemetics , 
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need of intravenous fluids were recorded . Any 
hospital admissions or visits to emergency department 
with nausea and vomiting prior to and in the month 
after her presentation were also recorded.Patient was 
labelled to have Hyperemesis Gravidarum (HG) if 
dehydration and electrolyte disturbances were present 
and >5% of pre-pregnancy weight was lost. The 24 
hour-PUQE score has three criterion : how long did the 
patient feel nauseated, how many times did the 
patients throw up and how many times did the patient 
retch or have a dry heave without throwing up over 
last  the preceeding 24 hours. Each criteria was given a 
score of 1-5 depending on how frequent or how long a 
particular symptom is experienced. The total score of 
upto 6 was taken as mild, 7-12 as moderate, and 
greater than 13 as severe.4 The PUQUE score was 
calculated and entered . The well being score was also 
calculated and noted in the performa . It is a score of  
self-perception of psychological and physical health 
provided by patient when asked to rate her general 
well-being . The well-being score ranges from 0 to 10 
.The worst possible well-being is rated as 0 and best 
well-being as 10 as compared with the woman’s health 
and well-being prior to pregnancy.4   Chi square and 
fisher-exact test were used to assess association 
between severity of PUQE score and, need for 
intravenous (IV) fluids, intravenous antiemetic, use of 
multivitamin, visits to emergency room (ER), presence 
of pallor and weight loss . One way ANOVA was used 
to compare severity of PUQE score and wellbeing 
score, patients’ blood pressure and pulse.  P value of  
<0.05  was taken as significant. 
 
Results 
A total of 117 patients presented with nausea, 
vomiting of pregnancy in the OPD and ER during the 
study period.  Majority (46.2%) were nulliparous 
(Table 1). .    At their presentation to hospital, the 
incidence of pallor, dehydration, weight loss was 
much higher in women with severe PUQE score as 
compared to those with moderate and mild PUQE 
scores.(Table 2). Among these, 51% women had ER 
visits while 19.6%  visited ER more than once with 
nausea and vomiting of pregnancy. Twelve pregnant 
women (10.26%) were diagnosed  with hyperemesis 
gravidarum. Women categorized as having severe 
PUQE score had higher pulse and lower systolic and 
diastolic blood pressure. However the association with 
systolic blood pressure did not reach statistical 
significance.(Table 2). All of the 10  patients with HG 
had severe PUQE score.      Similarly severity of PUQE 
score had significant association with different aspect  
Table  1: Demographic Profile 
variable Sub-category N % 
 Age Upto20 years 6 5.1 
21-30 years 91 77.8 
31-40  years 19 16.2 
>40   years 1 .9 
Gestational 
Age  
Upto 8 weeks 21 17.9 
9-13 weeks 83 70.9 
14-16 weeks 13 11.1 
Education Nil 28 23.9 
Primary 36 30.8 
Matric 25 21.4 
Graduate 13 11.1 
Prof education 15 21.8 
Parity Nulliparous 54 46.2 
Para1 33 28.2 
Multipara 29 24.8 
Grandmultipara 1 .9 
Profession Housewife 100 85.5 
Desk job 4 3.4 
Labourer 3 2.6 
Medical  7 6 
Others 3 2.6 
Table 2: Association of PUQE score  and  
studied variables 
Variable Mild 
N=64 
Moderate 
N=35 
Severe 
N=18 
P- 
value 
Intake of 
Multivitamin 
Yes 37 6 1 0.00 
No 27 29 17 
Hospital 
Admission 
Yes 1 5 15 0.00 
No 63 30 3 
Visit to ER Nil 48 9 0 0.00 
1 16 18 3 
2 0 8 13 
3 0 0 2 
Need of  
IV antiemetic 
Yes 2 8 18 0.00 
No 62 27 0 
Need of  
IV fluid 
Yes 4 10 18 0.00 
No 60 25 0 
Dehydration Yes 1 5 16 0.00 
No 63 28 2 
Pallor Yes 20 16 10 0.12 
No 44 19 8 
Weightloss Yes 0 6 12 0.00 
No 64 29 6 
Mean pulse 82.66 
(±4.86) 
85.71(±5.59) 91.17(±
4.12) 
0.00 
Mean systolic BP 106.79 
(±7.58) 
107.97 
(±5.38) 
103.28 
(±5.28) 
0.057 
Mean diastolc BP 73.12 
(±8.47) 
70.86 
(±7.62) 
66.11 
(±5.01) 
0.004 
 
of management assessed in this study. More hospital 
admissions and ER visits were seen in patients with 
severe PUQE score as compared to those with 
moderate and mild scores. All patients with severe 
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PUQE visited ER once or more with 13 out of 18 
patients visiting ER twice.(table 2) . All women found 
to have severe PUQE score needed intravenous fluids 
and intravenous emetics. (Table 2). Only 1 out of 18 
women with severe PUQE score was taking 
multivitamins at time of presentation as compared to 6 
out of 35 with moderate and 37 out of 64 with mild 
score.(table 2)  
Among the total 117 women presenting with NVP, 
64(54.7%) had mild, 35 (39.9%) had moderate and 
18(15.4%) had severe scores using the  24 hours PUQE 
score (Table 3). Severity of PUQE SCORE was 
reflecting deterioration of quality of life. (figure  1) 
 
Table 3: PUQE score 
Score N o(%)  
Mild 64 (54.70) 
Moderate 35 (29.91) 
High  18 (15.38) 
 
 
Figure 1 : Association of well being score and PUQE score 
p< 0.001 
 
Discussion 
Most expectant`` mothers suffer from nausea and 
vomiting of pregnancy (NVP) in the first trimester. 
The disease-burden can become substantial if 
symptoms are under-diagnosed and under-treated, 
thus permitting disease progression.7 A tool to gauge 
severity of NVP helps in timely and  proper 
management of patients which  is imperative.8-10 
In our study 15% women were  in severe PUQE score 
category as compared to the study by Koren et el (who 
devised PUQE score) in which 25. 5% patients had 
severe PUQE score.4 Another study on NVP in 
Norwegian women revealed 29.5 % women were 
categorized as having severe PUQE score .1 As in other 
studies most of the patients in our study  who  
presented with NVP were of younger age group, 
lower parity and were around 10 weeks gestation. 5,10,11 
We used external parameters that mirror clinically the 
severity of the woman’s symptoms to validate the 
modified PUQE score. We examined the rate of 
hospital admissions or ER  visits that could be 
attributed to NVP. Hospitalization and repeated visits 
to ER cause substantial disturbances in patients’ day to 
day lives and has financial impacts for patient, their 
families and hospital.11,12High PUQE-24 scores is 
shown to be associated with higher hospitalization 
rates and more ER visits in our study similar to a study 
done by the team who devised PUQE-24.4 Similarly 
other studies have shown women with higher PUQE 
score were associated with more frequent ER visits 
and hospital admissions1,5,13 This study shows that 
higher PUQE score is also associated with lower blood 
pressure,higher pulse, dehydration and weight loss. 
This recognizes the more susceptible group of patients 
at risk of developing HG that is who are dehydrated, 
hypotensive and in need of intravenous fluids and for 
whom oral antiemetics do not suffice. All women in 
our study with HG had severe PUQE score. Likewise 
in other studies, higher PUQE score was seen in 
women with HG.5,13 As intravenous fluids and 
intravenous antiemetics, needed in this patient 
population, cannot be administered at home so these 
patients need hospital admissions and frequent ER 
visits. Timely stratification of women with NVP  by 
PUQE score offers women and health-care givers with 
a chance to intervene before further deterioration of 
symptoms. This in turn may lead to need of hospital 
admission and repeated visits to ER.5,11 
 As in other studies, lowest multivitamin and 
nutritional supplement  use was seen in severe PUQE 
group followed by those with moderate PUQE score. 
So PUQE-24 scores were highly predictive of the 
inability to take multivitamins in cases of severe 
nausea. 1,,4,5,13.In general tablet folic acid are usually 
prescribed till 12-14 weeks gestation and iron plus folic 
acid and calcium plus vitamin C and D   at later 
gestations. Women with NVP have altered and 
intensified sense of taste and smell.12,14,15 This might 
make them attribute worsening of symptoms to 
multivitamin use 4,13 and they are unwilling to use 
even folic acid.16  These women may have difficulty is 
swallowing and retaining medications including 
multivitamins. Moreover  iron is related to severe 
nausea and gastrointestinal symptoms.13 Women tend 
to avoid nutritional supplements that may make their 
already severe NVP worse.13,16,17 
Well-being is considered as a subjective parameter. It 
shows a patient’s overall physical, mental and 
emotional health, demonstrating her quality of life at 
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the time of assessment. Our results reveal that PUQE-
24 scores strongly correlate with this self-rated 
parameter.  PUQE-24 can therefore be used in 
evaluating the severity of distress experienced by 
expectant mothers with NVP. This has been seen in 
other studies too where higher PUQE score was 
associated with lower  well being score.4,5,13     As seen 
in other studies, NVP  may occur at any time of day 
and night.  It adversely effects daily activities, eating , 
fluid intake and ability to manage domestic and job-
related responsibilities .Therefore a 24 hour score 
better reflects the severity of symptoms.4,18 
 
Conclusion 
The PUQE 24 seems to be a reliable tool for assessment 
of NVP symptoms. It is simple to use and can help in 
patients management and follow up. 
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